Jill Donigian

Title: The Innovative Contributions of Jill Donigian

Introduction

Jill Donigian is a notable inventor based in North Arlington, NJ, who has made significant contributions to the field of biochemistry. Her work primarily focuses on the structural biology of histone deacetylases, which are crucial in various biological processes.

Latest Patents

Jill Donigian holds a patent for the "Crystal structure of a deacetylase and inhibitors thereof." This invention provides three-dimensional structural information from a hyperthermophilic bacterium, which is a histone deacetylase-like protein (HDLP). The HDLP shares 35.2% amino acid sequence identity with human histone deacetylase (HDAC1). The patent further details the three-dimensional structural information of HDLP bound by inhibitor molecules. This information is instrumental in designing, isolating, and screening deacetylase inhibitor compounds capable of inhibiting HDLP, HDAC family members, and HDLP-related molecules. Additionally, the invention relates to nucleic acids encoding a mutant HDLP that facilitates the determination of the three-dimensional structure of HDLP in the presence of a zinc atom.

Career Highlights

Jill Donigian is affiliated with the Sloan-Kettering Institute for Cancer Research, where she applies her expertise in structural biology to advance cancer research. Her innovative work has the potential to impact therapeutic strategies for various diseases.

Collaborations

Jill has collaborated with esteemed colleagues, including Nikola P Pavletich and Michael Finnin, who share her commitment to advancing scientific knowledge in their respective fields.

Conclusion

Jill Donigian's contributions to the field of biochemistry, particularly through her patent on histone deacetylase-like proteins, highlight her role as an influential inventor. Her work continues to pave the way for future innovations in cancer research and therapeutic development.